Literature DB >> 17589324

Reduction of sortilin-1 in Alzheimer hippocampus and in cytokine-stressed human brain cells.

Yuhai Zhao1, Jian-Guo Cui, Walter J Lukiw.   

Abstract

Sortilin 1 (SORL1) is a transmembrane sorting receptor that regulates the intracellular trafficking of beta-amyloid precursor protein (betaAPP). Interactions between SORL1 and betaAPP result in the decreased processing of betaAPP into toxic amyloid-beta42 (Abeta42) peptides that accumulate in Alzheimer's disease brain. Here, we report selectively decreased levels of SORL1 in limbic and occipital regions of Alzheimer brain that inversely correlate with amyloid plaque and neurofibrillary tangle density. Reduced SORL1, coupled to elevated beta-amyloid cleaving enzyme, presenilin-1 and increased Abeta42 peptide secretion, was observed after incubation of cultured human neural cells with the proinflammatory cytokine interleukin-1beta. The results suggest that SORL1 deficits may not only promote the pathogenic processing of betaAPP but may also contribute to Abeta42-mediated inflammatory signaling in stressed human brain cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17589324     DOI: 10.1097/WNR.0b013e32821c56c4

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  13 in total

1.  Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases.

Authors:  Nicolas G Bazan; Miguel F Molina; William C Gordon
Journal:  Annu Rev Nutr       Date:  2011-08-21       Impact factor: 11.848

2.  Amyloid beta (Aβ) peptide modulators and other current treatment strategies for Alzheimer's disease (AD).

Authors:  Walter J Lukiw
Journal:  Expert Opin Emerg Drugs       Date:  2012-03-23       Impact factor: 4.191

Review 3.  Neuroprotectin D1 induces neuronal survival and downregulation of amyloidogenic processing in Alzheimer's disease cellular models.

Authors:  David T Stark; Nicolas G Bazan
Journal:  Mol Neurobiol       Date:  2011-03-10       Impact factor: 5.590

4.  An alternative transcript of the Alzheimer's disease risk gene SORL1 encodes a truncated receptor.

Authors:  Jenny Blechingberg; Annemarie Svane Aavild Poulsen; Mads Kjølby; Giulia Monti; Mariet Allen; Anne Kathrine Ivarsen; Sarah J Lincoln; Gangadaar Thotakura; Christian B Vægter; Nilüfer Ertekin-Taner; Anders Nykjær; Olav M Andersen
Journal:  Neurobiol Aging       Date:  2018-06-28       Impact factor: 4.673

5.  An Allosteric Binding Site on Sortilin Regulates the Trafficking of VLDL, PCSK9, and LDLR in Hepatocytes.

Authors:  Robert P Sparks; Andres S Arango; Jermaine L Jenkins; Wayne C Guida; Emad Tajkhorshid; Charles E Sparks; Janet D Sparks; Rutilio A Fratti
Journal:  Biochemistry       Date:  2020-11-05       Impact factor: 3.162

6.  Reduction of SorLA/LR11, a sorting protein limiting beta-amyloid production, in Alzheimer disease cerebrospinal fluid.

Authors:  Qiu-Lan Ma; Douglas R Galasko; John M Ringman; Harry V Vinters; Steven D Edland; Justine Pomakian; Oliver J Ubeda; Emily R Rosario; Bruce Teter; Sally A Frautschy; Greg M Cole
Journal:  Arch Neurol       Date:  2009-04

7.  Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease.

Authors:  Gary W Beecham; Eden R Martin; Yi-Ju Li; Michael A Slifer; John R Gilbert; Jonathan L Haines; Margaret A Pericak-Vance
Journal:  Am J Hum Genet       Date:  2009-01       Impact factor: 11.025

Review 8.  Docosahexaenoic acid and the aging brain.

Authors:  Walter J Lukiw; Nicolas G Bazan
Journal:  J Nutr       Date:  2008-12       Impact factor: 4.798

9.  Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPARγ-mediated mechanisms in Alzheimer's disease models.

Authors:  Yuhai Zhao; Frederic Calon; Carl Julien; Jeremy W Winkler; Nicos A Petasis; Walter J Lukiw; Nicolas G Bazan
Journal:  PLoS One       Date:  2011-01-05       Impact factor: 3.240

10.  Panel of Genetic Variations as a Potential Non-invasive Biomarker for Early Diagnosis of Alzheimer's Disease.

Authors:  Suk Ling Ma; Linda Chiu Wa Lam
Journal:  Clin Psychopharmacol Neurosci       Date:  2011-08-31       Impact factor: 2.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.